Trials / Sponsors / Exegenesis Bio
Exegenesis Bio
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU) Neovascular Age-Related Macular Degeneration (nAMD), Neovascular (Wet) Age-related Macular Degeneration (AMD) | Phase 1 | 2024-09-10 |
| Completed | A Study of EXG102-031 in Patients With wAMD (Everest) Neovascular (Wet) Age-related Macular Degeneration (nAMD) | Phase 1 | 2023-07-24 |